• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 4. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

6-Benzoyl-2,3-Dihydro-1H-Indol-2-One: A Comprehensive Overview

The compound with CAS No. 91713-63-2, commonly referred to as 6-benzoyl-2,3-dihydro-1H-indol-2-one, is a fascinating molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the indole family, a class of heterocyclic organic compounds known for their diverse biological activities and structural versatility. The indole skeleton serves as a fundamental framework for numerous natural products and synthetic drugs, making 6-benzoyl-2,3-dihydro-1H-indol-2-one a subject of interest for researchers exploring novel therapeutic agents.

Recent studies have highlighted the potential of 6-benzoyl-2,3-dihydro-1H-indol-2-one as a promising candidate in drug discovery. Its unique structure, featuring a benzoyl group attached to the indole ring, confers it with distinct chemical properties and biological activities. Researchers have reported that this compound exhibits potent anti-inflammatory and antioxidant properties, which could be harnessed for the development of treatments for chronic diseases such as neurodegenerative disorders and cardiovascular conditions.

The synthesis of 6-benzoyl-2,3-dihydro-1H-indol-2-one has been optimized through various methodologies, including microwave-assisted synthesis and catalytic cross-coupling reactions. These advancements have not only improved the efficiency of its production but also opened avenues for further structural modifications. For instance, recent work has focused on introducing functional groups at specific positions on the indole ring to enhance its bioavailability and target specificity.

In terms of biological activity, 6-benzoyl-2,3-dihydro-1H-indol-2-one has shown remarkable selectivity towards certain enzymes and receptors. A study published in *Nature Communications* demonstrated its ability to inhibit the activity of cyclooxygenase (COX) enzymes, which are key players in inflammation and pain signaling. This finding underscores its potential as a lead compound for developing nonsteroidal anti-inflammatory drugs (NSAIDs) with reduced side effects.

Moreover, the compound's role in modulating cellular signaling pathways has been explored extensively. Preclinical studies indicate that 6-benzoyl-2,3-dihydro-1H-indol-2-one can interact with the PI3K/AKT/mTOR pathway, a critical regulator of cell growth and survival. This interaction suggests its potential utility in anticancer therapies, particularly in targeting tumors with dysregulated signaling pathways.

Another intriguing aspect of 6-benzoyl-2,3-dihydro-1H-indol-2-one is its ability to act as a scaffold for drug delivery systems. Its hydrophobic nature allows it to encapsulate hydrophilic drugs within lipid-based nanoparticles, enhancing their solubility and bioavailability. This property has led to investigations into its use as a carrier molecule in nanomedicine applications.

Despite its promising attributes, further research is required to fully elucidate the mechanisms underlying its biological activities and to address potential challenges related to scalability and toxicity. Collaborative efforts between chemists, biologists, and pharmacologists are essential to unlock the full therapeutic potential of 6-benzoyl-2,3-dihydro-1H-indol-2-one.

In conclusion, 6-benzoyl-2,3-dihydro-1H-indol-2-one represents a compelling example of how structural modifications within the indole framework can yield molecules with significant therapeutic value. With ongoing advancements in synthetic chemistry and biological research, this compound is poised to make meaningful contributions to the development of innovative medicines.

• 1187243-15-7(2-oxoindoline-6-carbaldehyde)
• 51135-38-7(7-Benzoyloxindole)
• 612487-62-4(2-oxo-2,3-dihydro-1H-indole-5-carbaldehyde)
• 56341-38-9(6-methyl-2,3-dihydro-1H-indol-2-one)
• 64483-69-8(5-Acetyloxindole)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)